JP2007513903A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513903A5 JP2007513903A5 JP2006543431A JP2006543431A JP2007513903A5 JP 2007513903 A5 JP2007513903 A5 JP 2007513903A5 JP 2006543431 A JP2006543431 A JP 2006543431A JP 2006543431 A JP2006543431 A JP 2006543431A JP 2007513903 A5 JP2007513903 A5 JP 2007513903A5
- Authority
- JP
- Japan
- Prior art keywords
- permeation enhancer
- composition
- composition according
- aliphatic fatty
- terpene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003961 penetration enhancing agent Substances 0.000 claims 12
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 8
- -1 aliphatic fatty acid Chemical class 0.000 claims 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims 6
- 239000000194 fatty acid Substances 0.000 claims 6
- 235000007586 terpenes Nutrition 0.000 claims 6
- 150000003505 terpenes Chemical class 0.000 claims 5
- 239000005642 Oleic acid Substances 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 108010002156 Depsipeptides Proteins 0.000 claims 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims 3
- FSVJFNAIGNNGKK-UHFFFAOYSA-N Praziquantel Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 229960002957 praziquantel Drugs 0.000 claims 3
- OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical compound O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 claims 3
- ZMQMTKVVAMWKNY-YSXLEBCMSA-N Emodepside Chemical compound C([C@@H]1C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@H](C(O[C@H](CC=2C=CC(=CC=2)N2CCOCC2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O1)=O)CC(C)C)C(C=C1)=CC=C1N1CCOCC1 ZMQMTKVVAMWKNY-YSXLEBCMSA-N 0.000 claims 2
- 108010056417 emodepside Proteins 0.000 claims 2
- 229960001575 emodepside Drugs 0.000 claims 2
- 235000001510 limonene Nutrition 0.000 claims 2
- 229940087305 limonene Drugs 0.000 claims 2
- 229930007650 limonene Natural products 0.000 claims 2
- 235000020778 linoleic acid Nutrition 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N (+-)-(RS)-limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N 2-Pyrrolidone Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims 1
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- 244000079386 endoparasites Species 0.000 claims 1
- 125000000396 limonene group Chemical group 0.000 claims 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims 1
Claims (14)
- ・活性化合物として、環状デプシペプチドおよび/またはプラジカンテル
・ピロリドン溶媒
・テルペン透過増強剤および/または透過増強剤として作用する脂肪族脂肪酸および/または透過増強剤として作用する脂肪族脂肪アルコール
を含む組成物。 - テルペン透過増強剤としてテルペン炭化水素を含む、請求項1に記載の組成物。
- テルペン透過増強剤としてリモネンを含む、請求項2に記載の組成物。
- 透過増強剤として作用する脂肪族脂肪酸が、リノール酸またはオレイン酸である、請求項1に記載の組成物。
- 透過増強剤として作用する脂肪族脂肪酸がオレイン酸である、請求項1または請求項4に記載の組成物。
- テルペン透過増強剤および透過増強剤として作用する脂肪族脂肪酸を含む、請求項1に記載の組成物。
- テルペン透過増強剤がリモネンであり、透過増強剤として作用する脂肪族脂肪酸がオレイン酸またはリノール酸である、請求項6に記載の組成物。
- 透過増強剤として作用する脂肪族脂肪酸がオレイン酸である、請求項7に記載の組成物。
- 活性化合物として環状デプシペプチドを含む、請求項1ないし請求項8のいずれかに記載の組成物。
- 活性化合物としてエモデプシドを含む、請求項1ないし請求項9のいずれかに記載の組成物。
- 環状デプシペプチドおよびプラジカンテルを含む、請求項1ないし請求項9のいずれかに記載の組成物。
- エモデプシドおよびプラジカンテルを含む、請求項10または請求項11に記載の組成物。
- 活性化合物を、溶媒および必要に応じてさらなる補助剤と混合することを特徴とする、請求項1ないし請求項12のいずれかに記載の組成物の製造方法。
- 内寄生生物を制御するための、請求項1ないし請求項12のいずれかに記載の組成物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10358525A DE10358525A1 (de) | 2003-12-13 | 2003-12-13 | Endoparasitizide Mittel zur topischen Applikation |
DE10358525.7 | 2003-12-13 | ||
PCT/EP2004/013552 WO2005055973A2 (de) | 2003-12-13 | 2004-11-30 | Endoparasitizide mittel zur topischen applikation |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007513903A JP2007513903A (ja) | 2007-05-31 |
JP2007513903A5 true JP2007513903A5 (ja) | 2008-01-17 |
JP4842141B2 JP4842141B2 (ja) | 2011-12-21 |
Family
ID=34638681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006543431A Expired - Fee Related JP4842141B2 (ja) | 2003-12-13 | 2004-11-30 | 皮膚適用のための殺内寄生生物組成物 |
Country Status (32)
Country | Link |
---|---|
US (1) | US7763583B2 (ja) |
EP (1) | EP1694291B1 (ja) |
JP (1) | JP4842141B2 (ja) |
KR (1) | KR101272139B1 (ja) |
CN (1) | CN1893919B (ja) |
AR (1) | AR046878A1 (ja) |
AT (1) | ATE447940T1 (ja) |
AU (1) | AU2004296537B2 (ja) |
BR (1) | BRPI0417578B1 (ja) |
CA (1) | CA2548897C (ja) |
CR (1) | CR8428A (ja) |
DE (2) | DE10358525A1 (ja) |
DK (1) | DK1694291T3 (ja) |
ES (1) | ES2334920T3 (ja) |
GT (1) | GT200400264A (ja) |
HK (1) | HK1102915A1 (ja) |
HR (1) | HRP20100056T1 (ja) |
IL (1) | IL176151A (ja) |
MX (1) | MXPA06006594A (ja) |
MY (1) | MY142044A (ja) |
NO (1) | NO20063171L (ja) |
NZ (1) | NZ547837A (ja) |
PE (1) | PE20050919A1 (ja) |
PL (1) | PL1694291T3 (ja) |
PT (1) | PT1694291E (ja) |
RU (1) | RU2401108C2 (ja) |
SI (1) | SI1694291T1 (ja) |
TW (1) | TWI341202B (ja) |
UA (1) | UA85574C2 (ja) |
UY (1) | UY28662A1 (ja) |
WO (1) | WO2005055973A2 (ja) |
ZA (1) | ZA200604744B (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8119159B2 (en) | 1999-02-22 | 2012-02-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
US20070148228A1 (en) * | 1999-02-22 | 2007-06-28 | Merrion Research I Limited | Solid oral dosage form containing an enhancer |
DE102004055316A1 (de) * | 2004-11-16 | 2006-05-18 | Bayer Healthcare Ag | Verhinderung vertikaler Endoparasiten-Infektionen |
DE102005011779A1 (de) * | 2005-03-11 | 2006-09-14 | Bayer Healthcare Ag | Endoparasitizide Mittel |
MX2008012678A (es) | 2006-04-07 | 2008-12-17 | Merrion Res Iii Ltd | Forma de dosis oral solida que contiene un mejorador. |
CA2654566A1 (en) * | 2006-06-09 | 2007-12-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
PE20081406A1 (es) * | 2006-12-20 | 2008-10-17 | Schering Plough Ltd | Composiciones farmaceuticas de flunixina |
DE102008022520A1 (de) * | 2008-05-07 | 2009-11-12 | Bayer Animal Health Gmbh | Feste Arzneimittelformulierung mit verzögerter Freisetzung |
KR20110007242A (ko) * | 2008-05-07 | 2011-01-21 | 메리온 리서치 Ⅲ 리미티드 | 펩티드 조성물 및 그의 제조 방법 |
WO2010042395A1 (en) * | 2008-10-08 | 2010-04-15 | Wyeth Llc | Benzimidazole anthelmintic compositions |
US20100215743A1 (en) * | 2009-02-25 | 2010-08-26 | Leonard Thomas W | Composition and drug delivery of bisphosphonates |
DE102009012423A1 (de) | 2009-03-10 | 2010-09-16 | Bayer Animal Health Gmbh | Zubereitung auf Ölbasis |
AP2909A (en) | 2009-03-17 | 2014-05-31 | Concert Pharmaceuticals Inc | Pyrazinoisoquinoline Compounds |
WO2011013003A2 (en) | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
US20110182985A1 (en) * | 2010-01-28 | 2011-07-28 | Coughlan David C | Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof |
US9089484B2 (en) | 2010-03-26 | 2015-07-28 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor Xa inhibitors for oral administration |
CN103476419A (zh) | 2011-01-07 | 2013-12-25 | 梅里翁第三研究有限公司 | 口服投药的含铁药物组合物 |
US8680054B2 (en) * | 2011-04-20 | 2014-03-25 | Novartis Ag | Suspension type topical formulations comprising cyclic depsipeptide |
CN102283843A (zh) * | 2011-06-29 | 2011-12-21 | 梁晓天 | 一种吡喹酮外用制剂及其制备方法和应用 |
JP6185930B2 (ja) * | 2011-12-21 | 2017-08-23 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | 非晶質エモデプシド含有製剤 |
WO2014098619A1 (en) * | 2012-12-18 | 2014-06-26 | Donaghys Industries Limited | Transdermal parasiticidal formulations |
WO2015123480A2 (en) * | 2014-02-14 | 2015-08-20 | Dsm Ip Assets B.V. | Compositions and methods for the prevention and/or treatment of schistosomiasis |
ES2975708T3 (es) | 2015-01-29 | 2024-07-12 | Novo Nordisk As | Comprimidos que comprenden agonista del GLP-1 y recubrimiento entérico |
JP7045191B2 (ja) | 2015-05-20 | 2022-03-31 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 駆虫性デプシペプチド化合物 |
JP6943859B2 (ja) | 2015-12-28 | 2021-10-06 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 駆虫性デプシペプチド化合物 |
JP2020504710A (ja) | 2016-11-16 | 2020-02-13 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 駆虫性デプシペプチド化合物 |
EP3480195A1 (en) | 2017-11-07 | 2019-05-08 | Bayer Animal Health GmbH | Method for the synthesis of cyclic depsipeptides |
WO2019091975A1 (en) | 2017-11-07 | 2019-05-16 | Bayer Animal Health Gmbh | Method for the synthesis of cyclic depsipeptides |
CN111346046B (zh) * | 2020-03-06 | 2021-07-09 | 安徽农业大学 | 一种含莫西菌素注射用缓释凝胶制剂及制备方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US281292A (en) * | 1883-07-17 | onslow | ||
DE2362539C2 (de) | 1973-12-17 | 1986-05-07 | Merck Patent Gmbh, 6100 Darmstadt | 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE3619030A1 (de) * | 1986-06-06 | 1987-12-10 | Bayer Ag | Topisch anwendbare zubereitungen |
DE3634755A1 (de) * | 1986-10-11 | 1988-04-14 | Bayer Ag | Dermale behandlung von wurmerkrankungen der katze mit praziquantel |
NO176766C (no) | 1989-02-07 | 1995-05-24 | Meiji Seika Kaisha | Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet |
US5874479A (en) * | 1991-03-01 | 1999-02-23 | Warner-Lambert Company | Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same |
DE4317458A1 (de) | 1992-06-11 | 1993-12-16 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung |
DE4317457A1 (de) | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
DE4317432A1 (de) | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
DE4400464A1 (de) | 1994-01-11 | 1995-07-13 | Bayer Ag | Endoparasitizide Mittel |
NZ260018A (en) | 1994-03-03 | 1995-10-26 | Bomac Lab Ltd | Benzimidazole compositions and anthelmintic compositions |
DE19520275A1 (de) * | 1995-06-02 | 1996-12-05 | Bayer Ag | Endoparasitizide Mittel |
US5780487A (en) | 1995-08-07 | 1998-07-14 | Amer Moh Samir | S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide |
DE19601263A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | Anthelmintische Paste |
DE19628776A1 (de) | 1996-07-17 | 1998-01-22 | Bayer Ag | Oral applizierbare Granulate von Hexahydropyrazinderivaten |
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
DE19921887A1 (de) * | 1999-05-12 | 2000-11-16 | Bayer Ag | Endoparasitizide Mittel |
DE19941024A1 (de) | 1999-08-28 | 2001-03-01 | Hartmut Klocke | Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung |
US6340672B1 (en) | 2000-02-16 | 2002-01-22 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
DE10008128A1 (de) | 2000-02-22 | 2001-08-23 | Bayer Ag | Endoparasitizide Mittel |
DK1197215T3 (da) | 2000-10-10 | 2006-07-10 | Wyeth Corp | Anthelmintiske sammensætninger |
GB0108485D0 (en) | 2001-04-04 | 2001-05-23 | Pfizer Ltd | Combination therapy |
US6893652B2 (en) | 2001-08-27 | 2005-05-17 | Wyeth | Endoparasiticidal gel composition |
NZ542955A (en) * | 2003-04-04 | 2008-07-31 | Merial Ltd | At least one macrolide anthelmintic compound and a second anthelmintic agent, such as praziquantel, morantel and/or pyrantel, a non-aqueous solvent and a thickening agent to prevent endo- and ectoparasitic infections |
-
2003
- 2003-12-13 DE DE10358525A patent/DE10358525A1/de not_active Withdrawn
-
2004
- 2004-11-30 AT AT04798121T patent/ATE447940T1/de active
- 2004-11-30 AU AU2004296537A patent/AU2004296537B2/en not_active Ceased
- 2004-11-30 SI SI200431331T patent/SI1694291T1/sl unknown
- 2004-11-30 RU RU2006124964/15A patent/RU2401108C2/ru not_active IP Right Cessation
- 2004-11-30 KR KR1020067014014A patent/KR101272139B1/ko not_active IP Right Cessation
- 2004-11-30 BR BRPI0417578A patent/BRPI0417578B1/pt not_active IP Right Cessation
- 2004-11-30 UA UAA200607858A patent/UA85574C2/uk unknown
- 2004-11-30 DE DE502004010367T patent/DE502004010367D1/de active Active
- 2004-11-30 CN CN2004800371839A patent/CN1893919B/zh not_active Expired - Fee Related
- 2004-11-30 ES ES04798121T patent/ES2334920T3/es active Active
- 2004-11-30 MX MXPA06006594A patent/MXPA06006594A/es active IP Right Grant
- 2004-11-30 PL PL04798121T patent/PL1694291T3/pl unknown
- 2004-11-30 EP EP04798121A patent/EP1694291B1/de active Active
- 2004-11-30 PT PT04798121T patent/PT1694291E/pt unknown
- 2004-11-30 DK DK04798121.2T patent/DK1694291T3/da active
- 2004-11-30 JP JP2006543431A patent/JP4842141B2/ja not_active Expired - Fee Related
- 2004-11-30 NZ NZ547837A patent/NZ547837A/en not_active IP Right Cessation
- 2004-11-30 CA CA2548897A patent/CA2548897C/en not_active Expired - Fee Related
- 2004-11-30 WO PCT/EP2004/013552 patent/WO2005055973A2/de active Application Filing
- 2004-12-09 AR ARP040104591A patent/AR046878A1/es unknown
- 2004-12-09 UY UY28662A patent/UY28662A1/es not_active Application Discontinuation
- 2004-12-10 PE PE2004001220A patent/PE20050919A1/es not_active Application Discontinuation
- 2004-12-10 TW TW093138222A patent/TWI341202B/zh not_active IP Right Cessation
- 2004-12-10 MY MYPI20045106A patent/MY142044A/en unknown
- 2004-12-10 GT GT200400264A patent/GT200400264A/es unknown
-
2006
- 2006-06-01 CR CR8428A patent/CR8428A/es unknown
- 2006-06-06 IL IL176151A patent/IL176151A/en not_active IP Right Cessation
- 2006-06-09 ZA ZA200604744A patent/ZA200604744B/en unknown
- 2006-06-13 US US11/451,676 patent/US7763583B2/en active Active
- 2006-07-07 NO NO20063171A patent/NO20063171L/no not_active Application Discontinuation
-
2007
- 2007-07-10 HK HK07107397.7A patent/HK1102915A1/xx not_active IP Right Cessation
-
2010
- 2010-01-29 HR HR20100056T patent/HRP20100056T1/hr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007513903A5 (ja) | ||
CA2548897A1 (en) | Endoparasiticidal agents for topical application | |
JP2006271392A5 (ja) | ||
US9707187B2 (en) | Composition for enhancing transdermal absorption of a drug and patch preparation | |
WO2011146936A3 (en) | Self-assembled surfactant structures | |
NZ591261A (en) | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin | |
ECSP034430A (es) | Esteres oxigenados de acidos 4-yodo fenilamino benzhidroxamcios | |
WO2007133265A3 (en) | Adhesive with alkanoate blend | |
RU2006122181A (ru) | Система трансдермальной доставки никотина | |
UY27643A1 (es) | Formas de dosificación farmacéutica de liberación controlada de un inhibidor de la proteína de transferencia del éster de colesterilo | |
TW200631597A (en) | External use preparation and adhesive preparation thereof | |
JP2008513467A5 (ja) | ||
AU2001279631A1 (en) | Self-emulsifying active substance formulation and use of this formulation | |
EP1637167A3 (en) | New injectable formulations containing progesterone | |
EP2177531A3 (en) | Cell permeable peptide | |
CA2599334A1 (en) | External plaster containing flurbiprofen | |
ATE413865T1 (de) | Zusammensetzungen mit alphahydroxy-säureester zur wirkstofffreisetzung und anwendungsverfahren dafür | |
WO2006062933A3 (en) | Stable compositions of fenofibrate with fatty acid esters | |
WO2002030467A3 (en) | Pharmaceutical composition containing honey for the treatment of wounds | |
US20140255466A1 (en) | Composition for enhancing transdermal absorption of drug and patch preparation | |
EP2570122A1 (en) | Composition for Enhancing Transdermal Absorption of A Drug and Patch Preparation | |
WO2010020799A3 (en) | Compositions for the treatment of neoplastic diseases | |
EP2570116B1 (en) | Composition for enhancing transdermal absorption of a drug and patch preparation | |
CA2494568A1 (en) | Patches containing tulobuterol | |
UA83036C2 (ru) | Фармацевтическая композиция в виде гидрогеля для трансдермального введения в организм действующих веществ |